|
|
|
| home > ebr > Winter 2009 |
|
|
 PUBLICATIONS |
European Biopharmaceutical Review |
|
|
|
|
| At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. EBR provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of of biopharmaceuticals, take a look below at the range of articles featured in this issue of EBR |
 |
| |
|
|
|
| Independent consultant Emile Bellott looks at the changing biotech
landscape in light of the global financial crisis and considers the
likely implications for the global pharmaceutical/biotech industry |
|
|
| Mark B Hassenplug and Kai Gindner at Ernst & Young examine ways in which
pharmaceutical companies can maintain standards in supply chain management |
|
|
|
| Pharma and biotech companies often manage scientific assets and equipment on their own. Bob Moore at GE
Healthcare discusses why and how outsourcing scientific asset services can help to improve effectiveness in the lab |
|
|
| Catherine D’Arcy at PA Consulting Group describes the requirement for greater
efficiency and effectiveness in R&D operations and how working closely with
a global pharmaceutical company has prompted a review of key functions |
|
|
| Richard Barratt at Barratt Legal examines the proliferation of outsourcing
operational practices in the industry, and tells us how to get the best out of it |
|
|
|
| Mats Hellström and Björn Frendéus at BioInvent International examine the developments that
are occurring in monoclonal antibody drugs, and discuss their future in the fight against cancer |
|
|
| Birgit Jehn at QIAGEN GmbH gives an overview on HLA-Typing
or pre-therapeutic testing in AIDS patients |
|
|
|
|
| David Bunton and Lee Rankin at Biopta Ltd and Alistair Corbett at Glasgow
Caledonian University discuss opioid receptors as drug targets in gastrointestinal disorders |
|
|
| Graham Lappin at Xceleron argues that microdosing can provide important information about
a drug’s behaviour before Phase I, thereby reducing the likelihood of costly failures at a later stage |
|
|
|
| Ulrich Braumann at Bruker BioSpin and Herbert Thiele at Bruker Daltonik analyse
structure verification of small molecules using integrated MS spectrometry and NMR spectroscopy |
|
|
| Josep Prous at Thomson Reuters introduces biomarkers, identifying them
as a crucial factor in the evolution of drug research and development |
|
|
| LABALisette
Oversteegen at Datamonitor discusses combination
product market trends in the respiratory drug sector |
|
|
|
| R Keith Williams at The Clinical Biotechnology Centre, Bristol Institute for Transfusion Sciences, NHS Blood and Transplant and Angela Osborne of eXmoor pharma concepts ltd discuss small-scale biomanufacturing for clinical trials, cell and gene therapies in the UK market |
|
|
| Kate Westwell and Gina Wenham at Eden Biodesign explain
how implementing the quality cycle can deliver product value |
|
|
|
| Jacques Lhomel of Biocitech tells how one of Europe’s high-profile
life science parks has boosted resources for life sciences R&D |
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
PCI Clinical Services Announces Launch of FastTrackTM Service that Enables Rapid Delivery of Investigational Products to Patients
More info >> |
|
 |
White Papers |
 |
|
eSource: Reducing Site Workload for Better, Faster, Safer Clinical Trials
Clinical Ink
Unlike traditional electronic data capture (EDC),
SureSource, Clinical Ink’s eSource platform, was designed from the
beginning to minimize clinical trial complexity for site users. A Site Impact Survey provides
scientific evidence regarding the impact of SureSource from 517 site
users. Results confirm it significantly reduces workload, lessens
queries, and improves data quality compared to paper and EDC. In this
white paper, we quantitatively evaluate survey outcomes, provide
qualitative feedback from survey respondents, and highlight the observed
benefits of SureSource for transforming clinical research.
More info >> |
|
 |
Industry Events |
 |
Pharmapack Europe 2018
7-8 February 2018, Hall 7.1, Paris Expo, Porte de Versailles, Paris.
As Europe's dedicated Pharmaceutical Packaging
and Drug Delivery event, Pharmapack is the industry's go-to place to kick-off
the year.
More info >> |
|
|
